Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06739460

Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases

This study aims to compare the antinociceptive effects of ketamine and magnesium used in addition to midazolam, fentanyl, propofol and remifentanil agents preferred in hysteroscopy cases. It is conducted to observe the effect of ketamine and magnesium use on total additional propofol doses and additional remifentanil doses.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–55 year

Sex eligibility

Female

Study type

Observational

Primary location

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

About this study

Sedation is generally preferred in hysteroscopy cases. The most commonly used intravenous drugs are midazolam, fentanyl, propofol and remifentanil. Multimodal analgesia, which is intended to be provided in hysteroscopy cases, is a strategy that includes the use of two or more analgesic agents and techniques to provide adequate analgesia; and aims to minimize side effects such as bradycardia, hypotension, respiratory depression, pruritus, and postoperative nausea and vomiting. Multimodal analgesia improves patient and surgical comfort by applying additional drugs to existing agents, reduces postoperative complications, and thus helps to shorten hospital stays and reduce costs. Whether magnesium contributes to this multimodal analgesia will be investigated observationally, based on its antinociceptive effects.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA I-II patients
  • Patients aged 18-55
  • Patients undergoing hysteroscopy

Exclusion criteria

  • Patients who develop surgical complications during hysteroscopy
  • Patients with cardiovascular failure (ejection fraction <40%, patients with atrioventricular conduction disorder
  • Patients with history of cerebrovascular disease
  • Liver dysfunction (transaminases above normal level), Renal failure (creatine > 150 μmol/L),
  • Preoperative opioid use
  • History of neuromuscular disease
  • History of drug or alcohol abuse
  • Patients who develop the need for endotracheal intubation

Treatment and study plan

Primary outcomes

  1. Antinociceptive effects of ketamine and magnesium

    Time frame: During the hysteroscopic procedures.

    Observe the effect of ketamine and magnesium use on total additional doses of propofol and additional doses of remifentanil.

Sponsors and collaborators

Lead sponsor

SULEYMAN SARI

Other Gov

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 18, 2024
Registry last updated
Dec 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.